Novel compounds as opioid receptor modulators

Details for Australian Patent Application No. 2005224091 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Kavash, Robert W.; He, Wei; Cai, Chaozhong; Breslin, Henry J.

Agent Shelston IP

Pub. Number AU-B-2005224091

PCT Pub. Number WO2005/090315

Priority 60/553,342 15.03.04 US

Filing date 14 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 2 February 2012

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4172 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/454 (2006.01)

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090315 Priority application(s): WO2005/090315

2 February 2012 Application Accepted

  Published as AU-B-2005224091

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224092-Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis C viral infections

2005224089-A support structure